Big Changes, Uncertain Future - Avis employé Manager Merck

2,0
3 déc. 2009
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Merck has deep financial pockets. They used to be generous in their compensation. There are annual bonuses, stock options in addition to salary.

Inconvénients

Leadership is weak. The company does not accept new blood. Right now everyone is fearing for their jobs. The upcoming layoffs due to the recent merger is eating at everyone. Stress and tension is high.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout